222 related articles for article (PubMed ID: 16179927)
1. Engineering conditionally replication-competent adenoviral vectors carrying the cytosine deaminase gene increases the infectivity and therapeutic effect for breast cancer gene therapy.
Liu Y; Ye T; Maynard J; Akbulut H; Deisseroth A
Cancer Gene Ther; 2006 Apr; 13(4):346-56. PubMed ID: 16179927
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
Akbulut H; Zhang L; Tang Y; Deisseroth A
Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
[TBL] [Abstract][Full Text] [Related]
3. Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanoma.
Liu Y; Ye T; Sun D; Maynard J; Deisseroth A
Hum Gene Ther; 2004 Jul; 15(7):637-47. PubMed ID: 15242524
[TBL] [Abstract][Full Text] [Related]
4. The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines.
Peng XY; Won JH; Rutherford T; Fujii T; Zelterman D; Pizzorno G; Sapi E; Leavitt J; Kacinski B; Crystal R; Schwartz P; Deisseroth A
Cancer Res; 2001 Jun; 61(11):4405-13. PubMed ID: 11389068
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic adenoviral vector carrying the cytosine deaminase gene for melanoma gene therapy.
Liu Y; Deisseroth A
Cancer Gene Ther; 2006 Sep; 13(9):845-55. PubMed ID: 16710344
[TBL] [Abstract][Full Text] [Related]
6. Tumor-specific therapeutic effect induced by an oncolytic adenoviral vector containing heat shock protein 70 and prodrug activation genes.
Liu Y; Ye T; Sun D; Maynard J; Deisseroth A
Gene Ther; 2006 Aug; 13(16):1235-43. PubMed ID: 16617300
[TBL] [Abstract][Full Text] [Related]
7. A novel oncolytic adenovirus expressing Escherichia coli cytosine deaminase exhibits potent antitumor effect on human solid tumors.
Zhang J; Wei F; Wang H; Li H; Qiu W; Ren P; Chen X; Huang Q
Cancer Biother Radiopharm; 2010 Aug; 25(4):487-95. PubMed ID: 20735209
[TBL] [Abstract][Full Text] [Related]
8. Adenoviral vectors with E1A regulated by tumor-specific promoters are selectively cytolytic for breast cancer and melanoma.
Zhang L; Akbulut H; Tang Y; Peng X; Pizzorno G; Sapi E; Manegold S; Deisseroth A
Mol Ther; 2002 Sep; 6(3):386-93. PubMed ID: 12231175
[TBL] [Abstract][Full Text] [Related]
9. Construction of a novel oncolytic adenoviral vector and its biological characteristics.
Zhang M; Zhang X; Han Z; Chen X; Yang L; Sheng Y; Wen J
Oncol Rep; 2013 Feb; 29(2):798-804. PubMed ID: 23165979
[TBL] [Abstract][Full Text] [Related]
10. Recombinant adenoviral vector containing tumor-specific L-plastin promoter fused to cytosine deaminase gene as a transcription unit: generation and functional test.
Chung I; Deisseroth AB
Arch Pharm Res; 2004 Jun; 27(6):633-9. PubMed ID: 15283466
[TBL] [Abstract][Full Text] [Related]
11. Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation.
Garcia-Sanchez F; Pizzorno G; Fu SQ; Nanakorn T; Krause DS; Liang J; Adams E; Leffert JJ; Yin LH; Cooperberg MR; Hanania E; Wang WL; Won JH; Peng XY; Cote R; Brown R; Burtness B; Giles R; Crystal R; Deisseroth AB
Blood; 1998 Jul; 92(2):672-82. PubMed ID: 9657770
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic effect of a replication-incompetent adenoviral vector with cytosine deaminase gene driven by L-plastin promoter in hepatocellular carcinoma cells.
Jung K; Kim S; Lee K; Kim C; Chung I
Arch Pharm Res; 2007 Jun; 30(6):770-7. PubMed ID: 17679557
[TBL] [Abstract][Full Text] [Related]
13. Improvement of antitumor activity by gene amplification with a replicating but nondisseminating adenovirus.
Bourbeau D; Lau CJ; Jaime J; Koty Z; Zehntner SP; Lavoie G; Mes-Masson AM; Nalbantoglu J; Massie B
Cancer Res; 2007 Apr; 67(7):3387-95. PubMed ID: 17409449
[TBL] [Abstract][Full Text] [Related]
14. Vector targeting makes 5-fluorouracil chemotherapy less toxic and more effective in animal models of epithelial neoplasms.
Akbulut H; Tang Y; Maynard J; Zhang L; Pizzorno G; Deisseroth A
Clin Cancer Res; 2004 Nov; 10(22):7738-46. PubMed ID: 15570008
[TBL] [Abstract][Full Text] [Related]
15. Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells.
Chung I; Schwartz PE; Crystal RG; Pizzorno G; Leavitt J; Deisseroth AB
Cancer Gene Ther; 1999; 6(2):99-106. PubMed ID: 10195877
[TBL] [Abstract][Full Text] [Related]
16. E1A, E1B double-restricted adenovirus with RGD-fiber modification exhibits enhanced oncolysis for CAR-deficient biliary cancers.
Wakayama M; Abei M; Kawashima R; Seo E; Fukuda K; Ugai H; Murata T; Tanaka N; Hyodo I; Hamada H; Yokoyama KK
Clin Cancer Res; 2007 May; 13(10):3043-50. PubMed ID: 17505007
[TBL] [Abstract][Full Text] [Related]
17. Fetal muscle gene transfer is not enhanced by an RGD capsid modification to high-capacity adenoviral vectors.
Bilbao R; Reay DP; Hughes T; Biermann V; Volpers C; Goldberg L; Bergelson J; Kochanek S; Clemens PR
Gene Ther; 2003 Oct; 10(21):1821-9. PubMed ID: 12960972
[TBL] [Abstract][Full Text] [Related]
18. Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy.
Lamfers ML; Grill J; Dirven CM; Van Beusechem VW; Geoerger B; Van Den Berg J; Alemany R; Fueyo J; Curiel DT; Vassal G; Pinedo HM; Vandertop WP; Gerritsen WR
Cancer Res; 2002 Oct; 62(20):5736-42. PubMed ID: 12384532
[TBL] [Abstract][Full Text] [Related]
19. The alphavbeta5 integrin of hematopoietic and nonhematopoietic cells is a transduction receptor of RGD-4C fiber-modified adenoviruses.
Nagel H; Maag S; Tassis A; Nestlé FO; Greber UF; Hemmi S
Gene Ther; 2003 Sep; 10(19):1643-53. PubMed ID: 12923563
[TBL] [Abstract][Full Text] [Related]
20. A Bicistronic Adenoviral Vector Carrying Cytosine Deaminase and Granulocyte-Macrophage Colony-Stimulating Factor Increases the Therapeutic Efficacy of Cancer Gene Therapy.
Akbulut H; Coleri A; Sahin G; Tang Y; Icli F
Hum Gene Ther; 2019 Aug; 30(8):999-1007. PubMed ID: 30892086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]